Cerillion Reports Strong H1 2025 Trading Update with Major Contract Wins and Robust Cash Position
Cerillion's H1 2025: strong growth with $11.4m & £5.4m contracts, £31m net cash & upbeat outlook. Key trading update insights here.
This article covers information on Cerillion PLC.
LON:CERA Sterling Start: Cerillion Flexes Its Financial Muscles
Let’s cut through the spreadsheet fog – Cerillion’s H1 update is a masterclass in how to deliver a “soft landing” while simultaneously building momentum. The numbers? They’re telling a story of strategic timing, operational discipline, and a sales engine that’s purring like a Rolls-Royce engine.
The Financial Snapshot: More Nuanced Than a British Summer
At first glance, the headline figures might have you reaching for an umbrella:
- Revenue: £20.9m (H1 2024: £22.5m)
- Adjusted EBITDA: £10.0m (H1 2024: £11.0m)
But here’s where it gets interesting. That revenue dip isn’t a leak – it’s a timing issue. Cerillion’s wisely shifted major software renewals to H2, essentially borrowing from Peter to pay Paul. The result? A temporary H1 dip, but potentially a H2 bonanza.
Cash: The Unsung Hero
While revenue takes a breather, the balance sheet’s doing cartwheels:
- Net cash: £31.0m (up from £26.6m YoY)
- Debt: Noticeably absent from the report
In an era where cash is oxygen, Cerillion’s sitting on enough reserves to weather multiple market squalls. This isn’t just prudent – it’s borderline provocative in its financial health.
Contract Wins: The Art of Deal-Making
Cerillion’s sales team isn’t just hitting targets – they’re rewriting the playbook:
1. The Transatlantic Triumph
A juicy $11.4m deal in January – likely US-based given the dollar denomination. This isn’t just revenue; it’s a beachhead in the world’s largest telecom market.
2. The European Endorsement
£5.4m renewal with a major client isn’t just repeat business – it’s a ringing endorsement from a market that’s notoriously hard to please.
3. The Migration Megaproject
A European client’s decision to use Cerillion’s platform for a major customer migration is the golden ticket. This isn’t just H2 2025 revenue – it’s a multi-year annuity-style income stream.
The Pipeline: Fuller Than a City Pub at Happy Hour
Management’s noting a pipeline “a little ahead of last year’s record level”. Translation: The deal machine isn’t just humming – it’s accelerating.
Reading Between the Spreadsheet Lines
Three things savvy investors should note:
- Margin Magic: 48% EBITDA margin? That’s software economics at their finest
- Geographic Spread: US, Europe, and undisclosed emerging markets – diversification baked in
- Product Stickiness: Once a client’s running your BSS/OSS stack, they’re practically married to you
The Road Ahead: Why May Matters
With interim results due mid-May, watch for:
- H2 renewal figures – the proof of the timing pudding
- Any color on that mystery migration project
- Updates on the India/Bulgaria delivery centers’ efficiency gains
The Bottom Line: Cerillion’s Playing Chess
This isn’t a company reacting to markets – it’s shaping them. By front-loading implementation work and back-loading renewals, management’s engineered a growth escalator. The cash pile? That’s dry powder for acquisitions or a delicious special dividend.
In a world of SaaS companies burning cash like Formula 1 cars, Cerillion’s the electric speedboat – quiet, efficient, and leaving minimal wake. One to watch? More like one to study.
Cerillion at a Glance
- Established: 1999 (Management buyout from Logica)
- AIM Listing: Since 2016
- Special Sauce: Billing systems for telecoms (80+ clients across 45 countries)
- Global Reach: London HQ with tech hubs in India and Bulgaria
Related
Keep reading
Investing
Ten Technologies Preliminary Results 2026: Record EBITDA and Member Growth
Ten Technologies delivered record 2026 results as active members rose 23% and adjusted EBITDA increased 10% to £16.1 million.
JoshuaNovember 11, 2026
Investing
Winvia Entertainment completes The Online Giveaway Guys acquisition
Winvia Entertainment has completed its purchase of The Online Giveaway Guys' business and key assets, excluding liabilities, cash and receivables.
JoshuaNovember 10, 2026
Investing
RUA Life Sciences reaches positive adjusted EBITDA as Structural Heart spin-out reshapes the group
RUA Life Sciences expects £5.5 million revenue and £0.3 million adjusted EBITDA, but ABISS weakness and lower cash warrant attention.
JoshuaNovember 9, 2026
Last updated
Category
InvestingLikes
Star Rating
No ratings yet
Comments
No comments yet - start the conversation.